Clinical Trial Update: A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects. [Phase 1]

View source ↗

Summary

Phase 1 study to assess the mass balance of a radiolabeled compound [14C]HRS-8080 in healthy postmenopausal Chinese women; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HRS-8080

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 1 | Status: NOT_YET_RECRUITING